Traveler's Diarrhea Treatment Market Regional Demand, Top Players, Recent Trends, and Market Growth Forecast, 2027

[Priya]

Market Analysis: Global Traveler's Diarrhea Treatment Market

Traveler's diarrhea treatment market is growing at a substantial CAGR of 7.4% in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to the increasing cases of traveler’s diarrhea; which is boosting the traveler’s diarrhea treatment market.

Global Traveler's Diarrhea Treatment Market By Drugs Class (Anti-Motility Agents, Antibiotics and Others), Drugs (Lomotil, Imodium, Pepto-Bismol, Rifaximin and Others), Route of Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2027

Download Sample Report with related Graphs and Figures@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...

Market Definition: Global Traveler's Diarrhea Treatment Market

Traveler's diarrhea is a digestive tract disorder characterized by an intestinal infection that generally occurs when a person consume contaminated food and water. This infection generally spreads through intestinal pathogens contracted while traveling where here the climatic conditions and sanitary practices are different from their home. Symptoms include loose stools, abdominal cramps, nausea and vomiting.

According to Centers for Disease Control and Prevention, travelers’ diarrhea (TD) is the most prevalent and predictable travel related illness worldwide. The prevalence rate ranges from 30% to 70% of travelers globally, depending on the destination and season of travel.

Market Drivers

·       Worldwide growing tourism is accelerating the market growth for traveler's diarrhea treatment

·       Unhealthy lifestyle of people will drive the market growth in the forecast period

·       Poor sanitation in developing and underdeveloped countries is acting as catalyst to market growth

·       Rise in the healthcare expenditure globally will also boost the market growth

Market Restraints

·       Lack of awareness amongst people regarding sanitation in developing nations as well as underdeveloped nations will restraint the market growth

·       Side effects of the drugs such as constipation and headache may hamper the market growth

·       Unavailability of skilled professionals will restrict the market growth for traveler's diarrhea treatment

Click here for Detailed Analysis Report https://www.databridgemarketresearch.com/reports/global-travelers-d...

Competitive Analysis:

Global Traveler's diarrhea treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of traveler's diarrhea treatment for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

The key market players in the traveler's diarrhea treatment market are Bayer AG, Merck & Co., Inc, Johnson & Johnson Services, Inc, Novartis AG, Valneva SE, Shanghai United Cell Biotechnology Co.,Ltd, PaxVax, Inc, Immuron, Salix Pharmaceuticals, F. Hoffmann-La Roche Ltd, Basilea Pharmaceutica Ltd, Eli Lilly and Company, Delcath Systems Inc, BridgeBio Inc, Incyte Corporation, Agios, Inc among others.

Access Full Report@ https://www.databridgemarketresearch.com/checkout/buy/singleuser/gl...

Global AIDS Treatment Market Scope and Market Size:

Traveler's diarrhea treatment market is segmented of the basis of drugs class, drugs, route of administration, distribution channel and end user. The growth among these specific segments will help users analyze niche pockets of growth and strategies to approach the market and determine your core application areas and difference in your target markets.

Based on drugs class, the traveler's diarrhea treatment market is segmented as anti-motility agents, antibiotics and others.

Based on drugs, the traveler's diarrhea treatment market is segmented as lomotil, imodium, pepto-bismol, rifaximin and others.

Based on the route of administration, the traveler's diarrhea treatment market is segmented into oral, parenteral.

Based on the distribution channel, market is segmented as hospital pharmacy, online pharmacy, retail pharmacy.

Based on end user, the traveler's diarrhea treatment market is segmented into hospitals, homecare, specialty clinics and others

Complete Report is Available including full TOC@ https://www.databridgemarketresearch.com/toc/?dbmr=global-travelers...

Global Traveler's Diarrhea Treatment Market Country Level Analysis

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Israel, Egypt, Kuwait, Rest of Middle East and Africa as a part of Middle East and Africa, Argentina, Brazil, Peru and Rest of South America as part of South America.

Key Developments in the Market

·       In November 2018, COSMO PHARMACEUTICALS received the U.S FDA approval for Aemcolo (rifamycin), an antibacterial drug indicated to treat adult patients with travelers’ diarrhea which is caused by noninvasive strains of Escherichia coli (E. coli). The approval of Aemcolo can potentially change the treatment landscape and offers complete treatment for millions of people each year.

·       In February 2019, Dr. Falk Pharma GmbH is developing SV-MMX (Rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea. If trial gets successful, it will provide the potential treatment for patients suffering from travelers’ diarrhea across the globe

Related Trending Reports @

·       Bladder Disorders Market

·       Eating Disorders (EDs) Market

·       Neurological Biomarkers Market

·       Metagenomics Market

·       Sutures Market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: [phone]

Email: [e-mail]